News & insights

The UPC going beyond its borders: how your company can profit from the latest case law

The UPC now allows life sciences companies to enforce European patents more efficiently across multiple countries through its long-arm jurisdiction. This lets patent holders sue distributors based in UPC member states in a single action, even if products are sold or made in non-UPC countries. Following key rulings the UPC can issue cross-border injunctions covering several national patent parts, while respecting jurisdiction limits on patent validity challenges.

5 of 5 Insights

Revocation of life sciences patents in the UPC

The Unified Patent Court (UPC), active since June 2023, is seeing strong uptake in pharma and biotech. Revocation decisions show a balanced 50:50 win rate for patentees and challengers. Key legal standards on novelty, obviousness, and inventive step are emerging, though some aspects remain unclear. Strategic use of the UPC offers broad enforcement, but revocation risks are higher for single-patent portfolios. Legal uncertainties, like the Bolar exemption, still need clarification.

by Lydia Birch and Rebecca Limer

4 of 5 Insights

Consumer and Retail in the News

by multiple authors

Game, set and match! UK's Data (Use and Access) Act passes

by Debbie Heywood

The Procurement Act 2023: procurement challenges

by Katie Chandler and Matt Evans

Fashion and Luxury Market Update

by Jason Rawkins and Simon Jupp

Collective actions impacting big tech - Ireland set to test the boundaries in ICCL v Microsoft

by Ryan Ferry and Edwina Kelly